Neonatal hypoglycemia, early-onset diabetes and hypopituitarism due to the mutation in EIF2S3 gene causing MEHMO syndrome

Physiol Res. 2018 May 4;67(2):331-337. doi: 10.33549/physiolres.933689. Epub 2018 Jan 5.

Abstract

Recently, the genetic cause of several syndromic forms of glycemia dysregulation has been described. One of them, MEHMO syndrome, is a rare X-linked syndrome recently linked to the EIF2S3 gene mutations. MEHMO is characterized by Mental retardation, Epilepsy, Hypogonadism/hypogenitalism, Microcephaly, and Obesity. Moreover, patients with MEHMO had also diabetes and endocrine phenotype, but detailed information is missing. We aimed to provide more details on the endocrine phenotype in two previously reported male probands with MEHMO carrying a frame-shift mutation (I465fs) in the EIF2S3 gene. Both probands had a neonatal hypoglycemia, early onset insulin-dependent diabetes, and hypopituitarism due to dysregulation and gradual decline of peptide hormone secretion. Based on the clinical course in our two probands and also in previously published patients, neonatal hypoglycemia followed by early-onset diabetes and hypopituitarism may be a consistent part of the MEHMO phenotype.

MeSH terms

  • Diabetes Mellitus, Type 1 / congenital*
  • Diabetes Mellitus, Type 1 / genetics*
  • Endocrine Glands / metabolism
  • Epilepsy / genetics*
  • Eukaryotic Initiation Factor-2 / genetics*
  • Frameshift Mutation
  • Genitalia / abnormalities*
  • Humans
  • Hypoglycemia / congenital*
  • Hypoglycemia / genetics*
  • Hypogonadism / genetics*
  • Hypopituitarism / congenital*
  • Hypopituitarism / genetics*
  • Infant, Newborn
  • Male
  • Mental Retardation, X-Linked / genetics*
  • Microcephaly / genetics*
  • Obesity / genetics*
  • Phenotype
  • Transcription Factors

Substances

  • EIF2S3 protein, human
  • Eif2s3y protein, mouse
  • Eukaryotic Initiation Factor-2
  • Transcription Factors

Supplementary concepts

  • MEHMO syndrome